The U.S. Securities and Exchange Commission (SEC) added 12 China companies to their delisting watchlist.

Five Chinese companies face potential delisting from Wall Street if they fail to comply with new audit orders from the U.S. Securities and Exchange Commission (SEC).

Following its emergence from Chapter 11 bankruptcy protection, KaloBios is in the process of reacquiring company shares owned by its disgraced former CEO.

NephroGenex disclosed in a U.S. SEC filing that it had terminated Pierre Legault as CEO and president as well as Jaikrishna Patel, the company’s chief scientific officer.

STOCKHOLM–(BUSINESS WIRE)–Aerocrine (STO:AEROB) As previously announced, today is the last day of trading in the Aerocrine stock on Nasdaq Stockholm. Following completion of the recent public tender offer, Circassia Pharmaceuticals Plc (“Circassia”) has initiated a mandatory redemption procedure to acquire all shares not already held by Circassia. Further information on the redemption procedure will be […]